ERBB2 and neoplasm: Regarding fibroblasts, biglycanhigh HER2+ fibroblasts were less tumourigenic than biglycanlow HER2+ fibroblasts, which were related with the enhanced immunogenicity of the tumour mediated by the upregulation of MHC class I molecules and the downregulation of TGFβ [176].